Aris Miningの空売り状況は、投資家がAris Miningの株価下落に賭けている度合いを知ることができます。空売りデータは2週間ごとに更新されます。

Aris Mining (AMEX:ARMN) 株価情報, 空売り情報

Aris Mining

Aris Mining Corp is engaged in the acquisition, exploration, development, and operation of gold properties in Colombia, Guyana, and Canada. It owns and operates its Segovia Operations, Soto Norte Project and Marmato Mine in Colombia, the Toroparu Project in Guyana, and the Juby Project in Ontario, Canada. The company generates revenue from the sale of gold and silver.

Aris Mining Corp

Creating symmetrical, same-size gold nanospheres in microgravity that could accelerate speed and accuracy of blood tests for cancer, other diseases

News

Redwire Expands Drug Development In Microgravity With PIL-BOX And New Cancer-Detection Experiment On ISS

Health Care

General

CTSO

CytoSorbents Received $1.7M In Cash Proceeds From The Sale Of Its 2023 And Amended 2022 Net Operating Loss And R&D Tax Credits From The Technology Business Tax Certificate Transfer Program, Sponsored By The New Jersey Economic Development Authority

MLEC

Moolec Science Sa Announced That It Has Entered Into A Business Combination Agreement With Bioceres Group Limited and Other Related Entities In An All-stock Transaction

Earnings

Earnings Beats

HBT Finl Q1 2025 Adj. EPS $0.61 Beats $0.57 Estimate, Sales $58.014M Beat $57.380M Estimate

Biotech

ARVN

Arvinas Announced That New Preclinical Combination Data For ARV-393 Will Be Presented At The American Association For Cancer Research Annual Meeting

ROCKVILLE, Md. and SUZHOU, China, April 21, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPG#NASDAQ">AAPG</a>, HKEX: 6855))), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for hematological malignancies, today announced that two of its proprietary novel drugs have been included in the 2025 Chinese Society of Clinical Oncology (CSCO) Guidelines. Lisaftoclax (APG-2575), the company's investigational novel oral Bcl-2 selective inhibitor, received its first recommendation in the CSCO Guidelines for the Diagnosis and Treatment of Lymphoid Malignancies. Olverembatinib, the company's novel next-generation tyrosine kinase inhibitor (TKI), received an upgraded recommendation in the CSCO Guidelines for the Diagnosis and Treatment of Leukemias in Children and Adolescent, and retained its recommendations in the CSCO Guidelines for the Diagnosis and Treatment of Hematological Malignancies.
 &nbsp;

AAPG

Ascentage Pharma's Proprietary Novel Drugs Lisaftoclax And Olverembatinib Included In 2025 Chinese Society Of Clinical Oncology Guidelines

WIIM

IVVD

Invivyd shares are trading higher after the company signed a $30 million term loan facility with Silicon Valley Bank.

UTHR

United Therapeutics Announces Series Of Presentations And Sponsored Events At ATS 2025, Highlighting Pulmonary Hypertension And Fibrosis Studies

Financing

Invivyd Signs $30M Term Loan Facility With Silicon Valley Bank

Canaccord Genuity analyst Maria Ripps maintains Netflix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) with a Buy and raises the price target from $1150 to $1200.

Price Target

Analyst Ratings

NFLX

Canaccord Genuity Maintains Buy on Netflix, Raises Price Target to $1200

Guaranty Bancshares (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GNTY#NYSE">GNTY</a>) reported quarterly earnings of $0.75 per share which beat the analyst consensus estimate of $0.71 by 5.63 percent. This is a 29.31 percent increase over earnings of $0.58 per share from the same period last year. The company reported quarterly sales of $31.76 million which beat the analyst consensus estimate of $31.10 million by 2.13 percent. This is a 10.10 percent increase over sales of $28.84 million the same period last year.

GNTY

Guaranty Bancshares Q1 2025 GAAP EPS $0.75 Beats $0.71 Estimate, Sales $31.76M Beat $31.10M Estimate

Phillips 66 Urges Shareholders To Support Board Nominees In Response To Elliott's Conflicts Of Interest

Management

IMVT

Immunovant Has Appointed Eric Venker (Currently President And COO Of Roivant) Appointed As CEO, And Tiago Girao As CFO As Pete Salzmann Retires As Immunovant CEO And Director

Interim Analysis Of DESTINY-Breast 09 Phase III Trial Showd ENHERTU Plus Ertuzumab Demonstrated Statistically Significant And Clinically Meaningful Improvement In Progression-free Survival vs Taxane, Trastuzumab And Pertuzumab As  1st-Line Treatment For Patients With Her2-positive Metastatic Breast Cancer.

Raymond James analyst Josh Beck downgrades Amazon.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) from Strong Buy to Outperform and lowers the price target from $275 to $195.

Downgrades

AMZN

Raymond James Downgrades Amazon.com to Outperform, Lowers Price Target to $195

U.S. Vice President JD Vance arrived in India on Monday for a four-day visit aimed at progressing with bilateral ties and fast-tracking a significant trade deal.
While New Delhi rolled out a cultural welcome, the visit prompted grassroots protests from the All India Kisan Sabha (All India Farmers Union), which fears that the proposed agreement could threaten the livelihoods of Indian farmers.
What Happened: Vance, joined by his wife Usha Vance, their children, and senior U.S. officials is set to conduct meetings with Prime Minister Narendra Modi and make trips to Jaipur and Agra.
On April 18, the AIKS announced its decision to stage protests on April 21 in villages and district headquarters across India with the slogan "Vance Go Back! India Is Not For Sale," with plans for effigy burnings and rallies.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">
</blockquote></div></figure>

Politics

Global

JD Vance Faces Backlash From All India Farmers Union, Who Say Bilateral Trade Talks Will Undermine Farmers, Warn 'India Is Not For Sale'

Lavie Bio improves agriculture productivity and sustainability through microbiome-based ag-biological products
REHOVOT, Israel, April 21, 2025 /PRNewswire/ -- Evogene&nbsp;Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVGN#NASDAQ">EVGN</a>) (TASE: EVGN) a leading computational biology company focused on revolutionizing life-science-based product discovery and development, today announced the signing of a definitive agreement under which ICL, will acquire the majority of activity of Evogene's subsidiary, Lavie Bio Ltd. As part of the agreement, ICL will also acquire Evogene's MicroBoost AI for AG platform.
The transaction is expected to close during the second quarter of 2025, subject to the fulfillment of customary closing conditions.
 &nbsp;

EVGN

ICL To Acquire Majority Activity Of Evogene's Subsidiary Lavie Bio; Term Not Disclosed

Billionaire investor David Einhorn defied market gloom in Q1 2025 with a golden strategy that delivered standout gains for his hedge fund.
What Happened: Einhorn&#8217;s hedge fund, Greenlight Capital, outperformed the market in Q1 2025 by investing in gold, which surged 19% and was the &#8220;biggest winner&#8221; in its portfolio, <a href="https://www.businessinsider.com/david-einhorn-greenlight-capital-q1-letter-gold-sp500-bear-market-2025-4">reported</a> Business Insider.
Greenlight Capital reported an 8.2% return in the first quarter, significantly surpassing the S&amp;P 500&#8217;s loss of over 4% during the same period.
The hedge fund, which holds&nbsp;both gold bars and call&nbsp;options, also outperformed&nbsp;a benchmark of hedge funds.&nbsp;The average fund reported a loss of 0.4% in Q1,&nbsp;according to research group HFR.
Greenlight Capital also indicated that the U.S. equity market is entering a bear market. &#8220;Sensing that the market was turning, in late February we pivoted from conservative, but not bearish, to bearish,&#8221; the firm stated in its letter.
See Also:&nbsp;<a href="https://benzinga.com/news/25/04/44890771/a-couple-in-california-is-spending-1200-a-month-on-groceries-for-two-now-theyre-wondering-is-this-crazy" target="_blank" rel="noreferrer noopener">A Couple In California Is Spending $1,200 A Month On Groceries For Two. Now They&#8217;re Wondering, &#8216;Is This Crazy?&#8217;</a>
The firm has lowered its net equity exposure to shield itself from sharp declines and counter-trend upswings. It also identified other trades in its first-quarter letter, including short positions on companies catering to liberal tastes, long positions in SOFR futures, &#8220;tail protection&#8221; for the dollar, and long-duration inflation swaps.
Why It Matters: Speaking at the 2024 Sohn Investment Conference, Einhorn told CNBC that <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/04/38099167/greenlights-david-einhorn-is-loading-up-on-gold-as-a-hedge-against-something-not-so-good">inflation appears to be reaccelerating </a>and predicted the Federal Reserve may cut interest rates less than expected—possibly not at all. He warned of a potential economic downturn if tight monetary policy persists and said Greenlight has heavily invested in gold, including both SPDR Gold 
Furthermore,&nbsp;<a href="https://www.benzinga.com/news/25/04/44886209/if-you-had-bet-on-gold-after-the-1971-nixon-shock-youd-have-beaten-the-sp-500-unless-you-did-this-one-thing">historical data</a>&nbsp;suggests that gold investments can outperform the S&amp;P 500 during periods of economic uncertainty. This context adds weight to Greenlight Capital&#8217;s decision to invest in gold.
Moreover,&nbsp;<a href="https://www.benzinga.com/25/04/44860877/bearish-sentiment-surpasses-35-year-old-streak-breaking-all-records-hovers-above-50-for-eight-consecutive-weeks">bearish sentiment</a>&nbsp;has been on the rise, breaking a 35-year record and remaining above 50% for eight consecutive weeks. This trend aligns with Greenlight Capital&#8217;s&nbsp;assertion that the US equity&nbsp;market is entering a bear market. Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Read Next:&nbsp;<a href="https://benzinga.com/25/04/44891949/chinese-commerce-ministry-pledges-retaliation-against-countries-isolating-beijing-with-us-at-the-expense-of-china" target="_blank" rel="noreferrer noopener">Xi Jinping&#8217;s China Pledges Retaliation Against Countries Isolating Beijing By Giving Into Trump Administration&#8217;s &#8216;Unilateral Bullying,&#8217; Says It Will &#8216;Never Accept It&#8217;</a>
Photo courtesy: Shutterstock

Equities

Markets

As Stocks Slumped, This Strategy Delivered Big Gains For Top Hedge Fund Manager — Who Says Wall Street Is In Early Stages Of A Bear Market

As of April 21, 2025, two stocks in the utilities sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href="https://www.benzinga.com/topic/rsi">RSI is above 70</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>. 
Here's the latest list of major overbought players in this sector.
<h3 class="wp-block-heading">National Grid Plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NGG#NYSE">NGG</a>)</h3>
<ul>
<li>On Nov. 20, 2024, National Grid named Steve Smith as Chief Strategy and Regulation Officer. "It's a privilege to be appointed to this role at the most exciting time for the energy sector in decades," said Steve Smith "The strategy and regulation teams already deliver outstanding work to ensure National Grid is set up for success and that we continue to put our customers first. I am very much looking forward to continuing to build on this, as I take up the role on a permanent basis." The company's stock jumped around 13% over the past month and has a 52-week high of $73.40.</li>
<li>RSI Value: 70.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>NGG Price Action: Shares of National Grid gained 0.9% to close at $72.11 on Thursday.</li>
<li>Edge Stock Ratings: 81.39 Momentum score with Value at 61.01. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/quote/ngg"><img loading="lazy" decoding="async" width="498" height="193" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/21024550/image-31.png" alt="" class="wp-image-879013" style="width:436px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/21024550/image-31.png 498w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/21024550/image-31-300x116.png 300w" sizes="(max-width: 498px) 100vw, 498px" /></a></figure>
<h3 class="wp-block-heading">Korea Electric Power Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KEP#NYSE">KEP</a>)</h3>
<ul>
<li>The company's stock gained around 14% over the past month and <a href="https://www.benzinga.com/quote/KEP">has a 52-week high</a> of $9.42.</li>
<li>RSI Value: 71.9</li>
<li>KEP Price Action: Shares of Korea Electric Power fell 0.1% to close at $8.58 on Thursday.</li>
</ul>
How do other stocks rank? Get the full <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">BZ Edge Rankings breakdown here</a>. 
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44862261/top-3-materials-stocks-that-are-ticking-portfolio-bombs">Top 3 Materials Stocks That Are Ticking Portfolio Bombs</a> </li>
</ul>
Photo via Shutterstock

Short Ideas

Pre-Market Outlook

Trading Ideas

Top 2 Utilities Stocks That May Collapse This Month

MSCI

MSCI And Moody's Join Forces To Deliver Independent Risk Insights For Private Credit Investors

Offerings

Press Releases

ARIS MINING ANNOUNCES PRICING OF US$450 MILLION SENIOR NOTES OFFERING TO FUND REDEMPTION OF OUTSTANDING 6.875% SENIOR NOTES

ARIS MINING ANNOUNCES CLOSING OF US$450 MILLION SENIOR NOTES OFFERING TO FUND REDEMPTION OF OUTSTANDING 6.875% SENIOR NOTES

ARIS MINING ANNOUNCES Q3 2024 EARNINGS RELEASE DATE

ARIS MINING REPORTS Q3 2024 RESULTS WITH HIGHER GOLD PRODUCTION, INCREASED MARGIN GENERATION AT SEGOVIA AND PRO FORMA $266 MILLION CASH BALANCE

Commodities

ARIS MINING ANNOUNCES PROPOSED COLOMBIAN MINISTRY OF ENVIRONMENT RESOLUTION RELATED TO THE SANTURBÁN REGION

ARIS MINING ACHIEVES 2024 PRODUCTION GUIDANCE AND PROVIDES 2025 OUTLOOK

ARIS MINING ANNOUNCES FULL-YEAR 2024 EARNINGS RELEASE DATE

ARIS MINING ANNOUNCES COLOMBIAN MINISTRY OF ENVIRONMENT RESOLUTION RELATED TO THE SANTURBÁN REGION

ARIS MINING REPORTS RECORD Q4 2024 FINANCIAL RESULTS WITH STRONG EBITDA GROWTH AND ANNOUNCES 25% CAPACITY EXPANSION AT MARMATO

Small Cap

ARIS MINING REPORTS Q1 2025 GOLD PRODUCTION ACHIEVING 8% YEAR-OVER-YEAR GROWTH

ARMN

TSX:ARIS

Comments

Aris Mining

空売り

Aris Mining (AMEX:ARMN) 株価情報, 空売り情報

ニュース

パートナーシップ

ベンジンガ・グローバル